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Introduction
The Family Smoking Prevention and Tobacco Control Act (FSPTCA) 
of 2009 authorizes the US Food and Drug Administration (FDA) 
to regulate the manufacture, distribution, and marketing of tobacco 
products.1 Among other things, the regulations require retail stores 
that sell tobacco (“tobacco retailers”) to ensure that tobacco 
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Abstract
Importance: Single cigarettes, which are sold without warning labels and often evade taxes, can 
serve as a gateway for youth smoking. The Family Smoking Prevention and Tobacco Control Act 
of 2009 gives the US Food and Drug Administration (FDA) authority to regulate the manufacture, 
distribution, and marketing of tobacco products, including prohibiting the sale of single cigarettes. 
To enforce these regulations, the FDA conducted over 335 661 inspections between 2010 and 
September 30, 2014, and allocated over $115 million toward state inspections contracts.
Objective: To examine differences in single cigarette violations across states and determine if likely 
correlates of single cigarette sales predict single cigarette violations at the state level.
Design: Cross-sectional study of publicly available FDA warning letters from January 1 to July 31, 2014.
Setting: All 50 states and the District of Columbia.
Participants: Tobacco retailer inspections conducted by FDA (n = 33 543).
Exposure(s) for Observational Studies: State cigarette tax, youth smoking prevalence, poverty, and 
tobacco production.
Main Outcome(s) and Measure(s): State proportion of FDA warning letters issued for single ciga-
rette violations.
Results: There are striking differences in the number of single cigarette violations found by state, 
with 38 states producing no warning letters for selling single cigarettes even as state policymakers 
developed legislation to address retailer sales of single cigarettes. The state proportion of warning 
letters issued for single cigarettes is not predicted by state cigarette tax, youth smoking, poverty, 
or tobacco production, P = .12.
Conclusions and Relevance: Substantial, unexplained variation exists in violations of single ciga-
rette sales among states. These data suggest the possibility of differences in implementation of 
FDA inspections and the need for stronger quality monitoring processes across states implement-
ing FDA inspections.
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products are inaccessible to children and youth and restrict the sale 
of single cigarettes, or “loosies.”1 Despite these regulations, the sale 
of single cigarettes remains a problematic issue in many states and 
some are pursuing legislation above and beyond the FSPTCA to 
address their sale.2,3 Though single cigarettes are also commonly sold 
on the street by individuals as a way to generate income,4–6 for the 
purposes of this study we only focused on retailer sales as they are 
subject to FSPTCA regulations.
High availability of single cigarettes likely promotes smoking and 
undermines quit attempts, though some evidence suggests that exist-
ing smokers may use singles to try to cut down on smoking.7–9 Single 
cigarette sales often avoid taxes, and their lower up-front cost can 
make them more attractive to youth.10 Sale of single cigarettes is more 
common in neighborhoods with lower socioeconomic status and more 
racial/ethnic minority residents.10,11 Historically, retailers have been 
more willing to sell single cigarettes to racial/ethnic minority youth.12 
Landrine et al. found in the early 1990s that 39% of stores sold single 
cigarettes to youth in middle-class  California cities12; more recently, 
however, researchers in Ohio and North Carolina found that virtually 
no tobacco retailers advertised single cigarette sales in 2010 and 2011, 
respectively.13,14 It is likely that as the ban on single cigarettes has become 
more widely known, retailers have become less forthcoming about 
their sale. This was the case for a tobacco retailer education interven-
tion conducted in California; paid research staff conducted undercover 
buys of single cigarettes before and after an educational intervention 
with tobacco retailers. Prior to intervention, 68% of retailers who sold 
singles kept them behind the counter, while 100% of retailers selling 
singles kept them behind the counter post-intervention.15
With over 374 500 tobacco retailers in the United States,16 enforce-
ment of the FSPTCA’s ban on the sale of single cigarettes is relevant 
to addressing youth smoking as well as health disparities. Limited 
data exist to describe the phenomenon of single cigarette sales among 
tobacco retailers; much of the literature available presents informa-
tion from street sales and from inner cities,4,6,17 and data are not com-
parable across studies. To address this gap in the literature, we sought 
to examine national FDA inspection data for violations concerning 
the sale of single cigarettes by retailers and to identify predictors of 
differences in proportions of these violations by state.
Methods
The routine inspection of tobacco retailers is managed by the FDA 
and subcontracted to each state, often to a state agency. The FDA 
requires state contractors to conduct two types of inspections: one 
with youth purchase attempts known as Undercover Buy inspections 
and one conducted solely by adult inspectors, known as Advertising 
and Labeling (A&L) inspections.18 For the purposes of this article we 
only used data from A&L inspections, as those inspections send an 
FDA-credentialed adult to inspect tobacco retail stores for compliance 
with FDA regulations, among which the sale of single cigarettes is a 
violation. The FDA does not release the inspection protocol, though 
it is known that during the inspection of a tobacco retailer, inspec-
tors have the authority to visually scan the store, including parts not 
accessible to customers, for evidence of violations and interview store 
employees.19 If a retailer is found to be in violation of a provision of 
the FSPTCA, the retailer receives a warning letter in the mail that 
indicates the date of the inspection, the violation(s) observed dur-
ing the inspection, and instructions for responding to the FDA with 
a plan for correcting the violation. These warning letters contain 
standard language for different types of inspections. No information 
is available about state enforcement (which cannot be funded by the 
FDA and is separate from FDA enforcement).18 Retailers have 15 days 
to respond to the letter. Once a tobacco retailer receives a warning 
letter, the FDA conducts a follow-up inspection. If the retailer is still 
found to be in violation of the FSPTCA, the FDA may choose to 
administer a civil money penalty, or produce a no-tobacco-sale order.
We examined publicly available warning letters that were posted 
on the FDA Compliance Inspections website by September 2, 2014,20 
resulting from FDA inspections for compliance with provisions of 
the FSPTCA from January 1, 2014 to July 31, 2014, notifying retail-
ers in the 50 US states and District of Columbia of violations. These 
data constitute approximately 10% of all FDA inspections.
The FDA does not release specific sampling strategies for each state, 
and some states choose to oversample in areas with high proportions of 
racial/ethnic diversity, low-socioeconomic residents, and near schools; 
therefore, violation rates are not comparable across states. Thus, we 
compare the proportion of violations found during A&L inspections 
for state variation in order to assess both compliance with FSTPCA 
regulations and state implementation of compliance enforcement.
To see if the proportion of violations could be predicted by state-
level characteristics, we used Spearman rank-sum correlations and 
linear regression. We considered four possible explanations for single 
cigarettes sales. Single cigarette sales may be driven by demand from 
people with limited resources for purchasing full packs of cigarettes. 
We thus assessed the role of (1) state youth smoking prevalence21 and 
(2) the percentage of people living in poverty.22 Because single ciga-
rettes may be sold to evade taxes, we assessed the role of (3) state cig-
arette excise tax.23 Lastly, we thought historically tobacco-producing 
states may be more lenient towards the sale of single cigarettes; we 
thus assessed the role of (4) being a historically tobacco-producing 
state (GA, KY, NC, SC, TN, VA), as defined by Thrasher et al.24 We 
used two-tailed tests and a significance threshold of P < .05. To 
provide a visual representation of the heterogeneity of inspections, 
warning letters, and single cigarette violations across states, we geo-
coded25 each inspection to the street address listed in the letter and 
mapped these locations using QGIS 2.2 (www.qgis.org).
To ensure the reliability of our data, one author (HMB) coded 
each letter for type of violation reported, and a second author (JGLL) 
coded 10% of the letters, finding no discrepancies. Data used in this 
study were obtained from a publicly available data set and no human 
subjects were involved, therefore IRB approval was not sought.
Results
During the 7-month time period, FDA’s contractors completed 
a total of 33 543 A&L inspections in 49 states and the District 
of Columbia (Figure  1a). Thirty-nine states issued one or more 
warning letters in the time period analyzed, indicating that 2.1% 
of inspections (n = 718) resulted in a warning letter (Figure 1b). 
Warning letters were not proportionally distributed across states; 
12 states had zero violations while one state (North Carolina) 
had 107 (Table 1) (M = 15.3, SD = 24.7). Other states with rel-
atively high numbers of warning letters were Colorado (n = 41), 
Illinois (n = 80), Michigan (n = 48), South Carolina (n = 90), and 
Washington (n = 52). Finally, of all warning letters issued, 13.6% 
included a violation for single cigarette sales (Figure 1c). Numbers 
of warning letters for single cigarettes varied greatly across states: 
38 states produced no warning letters for selling single cigarettes, 
while one state, North Carolina, produced 64, the highest of any 
state (M = 6.3, SD = 12.5).
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Figure 1. (a) Location of inspections, (b) location of warning letters by state, and (c) location of warning letters for single cigarette violations, January–July 2014.
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To test if the proportion of warning letters issued for single cig-
arettes could be predicted by four factors, we first assessed bivari-
ate correlations with youth smoking prevalence (rs = 0.10, P = .47), 
poverty (rs  =  0.21, P  =  .14), state cigarette excise tax (rs  =  −0.05, 
P =  .73), and being a tobacco-producing state (rs = 0.23, P =  .10). 
None achieved statistical significance. We then ran a linear regression 
model containing all of these variables at the state level. This, too, did 
not achieve statistical significance, R2 = 0.14, F(4,50) = 1.93, P = .12.
Lastly, by mapping each inspection, warning letter, and single 
cigarette violation, we provide a visual illustration of the variation 
that existed in inspections and violations across states. The map indi-
cated substantive variation in the number of inspections conducted 
in states, in the number of violations identified, and in the location of 
single cigarette violations. Inspections tended to be clustered towards 
the east coast (California is noticeably absent), and warning letters 
as well as single cigarette sale violations were primarily clustered in 
North and South Carolina (Figure 1, a–c).
Discussion
Principal Findings
Tobacco retailer inspections under the FSPTCA produce striking varia-
tion in the proportion of warning letters for single cigarette sales. One 
state, North Carolina, had a substantially higher percentage of warning 
letters issued for single cigarette violations. These differences could not 
be predicted at the state level by known or suspected correlates of sin-
gle cigarette sales (ie, youth smoking rate, percent poverty rate, excise 
taxes, or being a tobacco producing state). Moreover, reports of retailer 
single cigarette sales as a problem in the media do not seem to parallel 
FDA inspection results. Lawmakers in Michigan, for example, have 
identified retailer single cigarette sales as a problem and are pursuing 
legislation.3 In addition, Detroit’s police chief has asked retailers to 
address the sale of singles26; yet, Michigan shows no warning letters for 
single cigarettes out of 395 statewide inspections (Table 1). Researchers 
provide evidence for the availability of single cigarettes at retailers in 
Baltimore6,8; this, too, is not reflected in FDA violations. Similar incon-
sistencies appear in other states.27,28 We know of no evidence that 
tobacco retailer violations should vary so extremely between states. 
Synar Amendment reports, for example, show less extreme differences 
in youth purchase rates between states than we have identified.29 Were 
retailers equally likely to violate the FSPTCA across states, our data 
indicate there may be problematic differences in the implementation of 
compliance efforts by state agencies on behalf of the FDA.
These discrepancies indicate that states may not be fully leverag-
ing the FDA’s A&L inspections to promote retailer compliance with 
legislation and maximize public health protection. Previous research 
shows wide variation in state implementation of (and resistance to) 
federal inspection programs.30,31 We suggest that it is therefore reason-
able to hypothesize that, based on FDA inspections data presented in 
this paper, similar variation is occurring in FDA’s current inspections 
program. This notion is further supported by our results showing that 
certain characteristics, which we posited to be associated with single 
cigarette sales, were not predictive of violations according to warning 
letters sent by the FDA inspections programs. In response to these data, 
efforts to assess the quality of state implementation of A&L inspec-
tions is likely needed to augment current FDA enforcement resources.
Strengths and Limitations
This article is not without limitations. First, neither our study design 
nor the available data permit us to causally infer the reasons for state-
level differences. Second, state contracts with the FDA may lapse or 
not be in place during different periods of the year. Third, while we use 
the proportion of violations instead of the violation rate, our research 
would be stronger if inspections had known sampling weights. Fourth, 
the data analyzed only includes retailer sales of single cigarettes, which 
Table 1. State Warning Letters for Single Cigarette Violations, 
n = 718, January 1–July 31, 2014
State A&L totals
State Inspections Warning letters
Singles (n, % of warning 
letters)
AL 1411 12 1, 8%
AK 60 0 0
AZ 154 11 0
AR 1022 11 0
CA 157 0 0
CO 739 41 0
CT 39 19 1, 5%
DE 250 0 0
DC 71 0 0
FL 147 1 0
GA 343 1 0
HI 56 0 0
ID 310 0 0
IL 715 80 0
IN 2515 8 0
IA 822 9 0
KS 839 1 0
KY 668 2 0
LA 669 2 0
ME 1315 3 0
MD 137 1 0
MA 1414 5 0
MI 395 48 0
MN 1253 24 0
MS 1513 2 0
MO 657 24 0
MT 154 11 1, 9%
NE 33 3 0
NV 75 17 5, 29%
NH 92 12 0
NJ 515 14 0
NM 114 0 0
NY 246 6 2, 33%
NC 1387 107 64, 60%
ND 0 0 0
OH 91 0 0
OK 512 3 1, 33%
OR 57 1 0
PA 1982 13 0
RI 305 2 0
SC 3817 90 9, 10%
SD 31 9 0
TN 167 10 2, 20%
TX 1765 18 3, 17%
UT 247 0 0
VT 67 0 0
VA 651 13 0
WA 2816 52 5, 10%
WV 537 8 1, 13%
WI 170 24 3, 13%
WY 41 0 0
Total 33 543 718 98, 13.6%
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account for only a portion of the single cigarettes available; single 
cigarettes are also available on the streets through informal means, 
where individuals will sell single cigarettes as a strategy for generating 
income.4–6 However, there are several strengths. We used national data 
from over 33 000 inspections conducted in 49 states and the District 
of Columbia and data come from a formalized inspections protocol 
implemented by FDA Officers that allows for inspections of areas of 
retailers not accessible to the public (or to researchers).
Unanswered Questions and Future Directions
Future research should assess the reasons for differences in single ciga-
rette sales violations of FSPTCA. It is plausible that the composition 
of retailers, differences in retailer trade group training, and differences 
in state-level retailer education may be partially responsible for these 
differences. Additional programmatic reasons could account for differ-
ences, including characteristics of FDA inspectors, inspection sampling 
strategies, and inspector quality improvement protocols. However, we 
remain concerned that unexplained variation in rates of single cigarette 
warning letters may also suggest that there are differences in the way 
inspection protocols are implemented regarding single cigarette sales.
Conclusion
To ensure compliance with the FSPTCA, the FDA invests significant 
resources in tobacco retailer inspections, having conducted over 
335 661 inspections between June 2010 and September 2014, and 
allocating over $115 million toward state inspections contracts.20,32 
Unfortunately, despite the policy change and economic resources 
committed to enforcing it, substantial, unexplained variation exists 
in inspections by state, particularly violations of single cigarette sales. 
These data suggest the possibility of differences in implementation 
of FDA inspections between states and the need for stronger quality 
monitoring processes across states implementing FDA inspections. 
Given the large investment in these inspections and the important 
role they play in reducing tobacco use at a population level, further 
investigation is needed to identify ways to optimize state tobacco 
retailer inspections, thereby maximizing the health impact of these 
regulations and policies at the population level.
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